Suppr超能文献

抗生素暴露强度对艰难梭菌感染风险的影响。

Influence of Antibiotic Exposure Intensity on the Risk of Clostridioides difficile Infection.

机构信息

Department of Pharmacy Practice, Oregon State University College of Pharmacy, Portland, Oregon, USA.

Oregon Health & Science University-Portland State University School of Public Health, Portland, Oregon, USA.

出版信息

Clin Infect Dis. 2024 Nov 22;79(5):1129-1135. doi: 10.1093/cid/ciae259.

Abstract

BACKGROUND

Antibiotics are a strong risk factor for Clostridioides difficile infection (CDI), and CDI incidence is often measured as an important outcome metric for antimicrobial stewardship interventions aiming to reduce antibiotic use. However, risk of CDI from antibiotics varies by agent and dependent on the intensity (ie, spectrum and duration) of antibiotic therapy. Thus, the impact of stewardship interventions on CDI incidence is variable, and understanding this risk requires a more granular measure of intensity of therapy than traditionally used measures like days of therapy (DOT).

METHODS

We performed a retrospective cohort study to measure the independent association between intensity of antibiotic therapy, as measured by the antibiotic spectrum index (ASI), and hospital-associated CDI (HA-CDI) at a large academic medical center between January 2018 and March 2020. We constructed a marginal Poisson regression model to generate adjusted relative risks for a unit increase in ASI per antibiotic day.

RESULTS

We included 35 457 inpatient encounters in our cohort. Sixty-eight percent of patients received at least 1 antibiotic. We identified 128 HA-CDI cases, which corresponds to an incidence rate of 4.1 cases per 10 000 patient-days. After adjusting for known confounders, each additional unit increase in ASI per antibiotic day was associated with 1.09 times the risk of HA-CDI (relative risk = 1.09; 95% CI: 1.06-1.13).

CONCLUSIONS

The ASI was strongly associated with HA-CDI and could be a useful tool in evaluating the impact of antibiotic stewardship on HA-CDI rates, providing more granular information than the more commonly used DOT.

摘要

背景

抗生素是艰难梭菌感染(CDI)的一个强有力的危险因素,CDI 的发病率通常被作为衡量旨在减少抗生素使用的抗菌药物管理干预措施的重要结果指标。然而,抗生素导致 CDI 的风险因药物种类而异,且取决于抗生素治疗的强度(即谱和持续时间)。因此,管理干预措施对 CDI 发病率的影响是不同的,要了解这种风险,需要对治疗强度进行比传统使用的治疗天数(DOT)等措施更细致的衡量。

方法

我们进行了一项回顾性队列研究,以衡量抗生素治疗强度(由抗生素谱指数 [ASI] 衡量)与 2018 年 1 月至 2020 年 3 月期间一家大型学术医疗中心发生的医院相关性 CDI(HA-CDI)之间的独立关联。我们构建了边缘泊松回归模型,以生成每增加一个 ASI 单位/抗生素日的调整后相对风险。

结果

我们的队列纳入了 35457 例住院患者。68%的患者至少接受了一种抗生素治疗。我们确定了 128 例 HA-CDI 病例,其发病率为每 10000 个患者日 4.1 例。在调整了已知混杂因素后,每增加一个 ASI 单位/抗生素日与 HA-CDI 的风险增加 1.09 倍(相对风险=1.09;95%CI:1.06-1.13)。

结论

ASI 与 HA-CDI 密切相关,可作为评估抗菌药物管理对 HA-CDI 发生率影响的有用工具,提供比更常用的 DOT 更细致的信息。

相似文献

本文引用的文献

7
Principles of confounder selection.混杂因素选择原则。
Eur J Epidemiol. 2019 Mar;34(3):211-219. doi: 10.1007/s10654-019-00494-6. Epub 2019 Mar 6.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验